Altimmune to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

Group 1 - Altimmune, Inc. will report its second quarter 2024 financial results on August 8, 2024, and provide a business update [1] - A conference call will be hosted by Altimmune management at 8:30 am E.T. on the same day to discuss the financial results [1] - The conference call will be available via live webcast on Altimmune's Investor Relations website [1] Group 2 - Altimmune is a clinical-stage biopharmaceutical company focused on developing next-generation peptide-based therapeutics [2] - The company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist aimed at treating obesity and MASH [2]